Stock Track | CSPC PHARMA Soars 13.48% Intraday Amid Broad Rally in Innovative Drug Sector-To The Moon - Tiger Brokers Online Investing Community

Like
Comment
Favorite

Stock Track | CSPC PHARMA Soars 13.48% Intraday Amid Broad Rally in Innovative Drug Sector

Stock Track03-27

CSPC PHARMA's stock surged 13.48% during intraday trading on Friday, breaking through multiple moving averages as part of a broader rally in the innovative drug sector.

The surge comes amid strong momentum across A+H innovative drug stocks, with sector ETFs seeing significant gains and heavy trading volume. More than 45 out of 50 constituent stocks in the Hong Kong Stock Connect Innovative Drug ETF traded higher, with CSPC PHARMA leading the gains.

Industry analysts point to several catalysts driving the sector rally, including the release of 2025 annual reports showing strong profitability among innovative drug companies, upcoming industry conferences like AACR and ASCO, and robust business development deal activity. The sector has been in correction for two quarters, making current valuations attractive for investors seeking exposure to innovative drug companies.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1184370574?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 13:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184370574","market":"sg","top_or_hot":-1,"title":"Stock Track | CSPC PHARMA Soars 13.48% Intraday Amid Broad Rally in Innovative Drug Sector","media":"Stock Track","content":"<p>CSPC PHARMA's stock surged 13.48% during intraday trading on Friday, breaking through multiple moving averages as part of a broader rally in the innovative drug sector.</p><p>The surge comes amid strong momentum across A+H innovative drug stocks, with sector ETFs seeing significant gains and heavy trading volume. More than 45 out of 50 constituent stocks in the Hong Kong Stock Connect Innovative Drug ETF traded higher, with CSPC PHARMA leading the gains.</p><p>Industry analysts point to several catalysts driving the sector rally, including the release of 2025 annual reports showing strong profitability among innovative drug companies, upcoming industry conferences like AACR and ASCO, and robust business development deal activity. The sector has been in correction for two quarters, making current valuations attractive for investors seeking exposure to innovative drug companies.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CSPC PHARMA Soars 13.48% Intraday Amid Broad Rally in Innovative Drug Sector</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CSPC PHARMA Soars 13.48% Intraday Amid Broad Rally in Innovative Drug Sector\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-27 13:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CSPC PHARMA's stock surged 13.48% during intraday trading on Friday, breaking through multiple moving averages as part of a broader rally in the innovative drug sector.</p><p>The surge comes amid strong momentum across A+H innovative drug stocks, with sector ETFs seeing significant gains and heavy trading volume. More than 45 out of 50 constituent stocks in the Hong Kong Stock Connect Innovative Drug ETF traded higher, with CSPC PHARMA leading the gains.</p><p>Industry analysts point to several catalysts driving the sector rally, including the release of 2025 annual reports showing strong profitability among innovative drug companies, upcoming industry conferences like AACR and ASCO, and robust business development deal activity. The sector has been in correction for two quarters, making current valuations attractive for investors seeking exposure to innovative drug companies.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01093","symbol_name":"石药集团","start_time":0,"source_url":"","article_id":"1184370574","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184370574","pubTimestamp":1774590292,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"CSPC PHARMA's stock surged 13.48% during intraday trading on Friday, breaking through multiple moving averages as part of a broader rally in the innovative drug sector.The surge comes amid strong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01093":"石药集团"},"translate_title":"个股追踪|创新药板块普涨石药盘中大涨13.48%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01093":1},"content_text":"CSPC PHARMA's stock surged 13.48% during intraday trading on Friday, breaking through multiple moving averages as part of a broader rally in the innovative drug sector.The surge comes amid strong momentum across A+H innovative drug stocks, with sector ETFs seeing significant gains and heavy trading volume. More than 45 out of 50 constituent stocks in the Hong Kong Stock Connect Innovative Drug ETF traded higher, with CSPC PHARMA leading the gains.Industry analysts point to several catalysts driving the sector rally, including the release of 2025 annual reports showing strong profitability among innovative drug companies, upcoming industry conferences like AACR and ASCO, and robust business development deal activity. The sector has been in correction for two quarters, making current valuations attractive for investors seeking exposure to innovative drug companies.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}